Details for 2020708283

Up to date per 02.04.2026

Actions

Title / Product Name

VERWENDUNG VON MIGALOSTAT ZUR VERRINGERUNG DES RISIKOS DES ZEREBROVASKULÄREN EREIGNISSES BEI PATIENTEN MIT FABRY-KRANKHEIT

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020708283

EP Publication Number

3914247

E-Number

1741131

Language

PCT Number

US20014531

Publication Date

01.12.2021 A

13.11.2024 B1

Registration Date

13.11.2024

AT Publication Date

15.12.2024

Application Date

22.01.2020

Registration Number

Priorities

22.01.2019

201962795524 P

IPC

A61K 31/445 20060101AFI20200803BHEP

Maximum Duration of Protection

22.01.2040

Owner

Amicus Therapeutics, Inc.3675 Market Street Philadelphia, PA 19104US

Representative

No representatives present

Inventor

SKUBAN, NinaAmicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury, New Jersey 08512US

LAGAST, HjalmarAmicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury, New Jersey 08512US

Information about Fees